Paper - WANFANG MED ONLINE

You Position: Home > Paper

子宫腺肌病保守性治疗的新进展

( views:407, downloads:542 )

Author:: No author available

Journal Title:: Chinese Journal of Obstetrics and Gynecology

Issue:: 3

DOI:: 10.3760/cma.j.issn.0529-567x.2013.03.021

Key Word:: No keyword available

Abstract：子宫腺肌病(腺肌病)是[1]指子宫内膜腺体和间质存在于子宫肌层中,伴随周围肌层细胞的代偿性肥大和增生.临床主要表现是月经量增多和经期延长(40％～ 50％),以及逐渐加剧的进行性痛经(25％)[1],其病因至今不清楚.腺肌病患者中,15％～40％合并内异症,而内异症患者不孕率高达50％,严重影响患者生命质量及家庭、社会的和谐与稳定,所以对腺肌病的防治工作已然成为临床及科研工作者面临的一项挑战[1-3].而对于年轻、有生育要求或不愿意接受手术切除子宫的患者来说,规范、确切的保守性治疗便显得愈加重要.近年来随着相关研究的深入,对腺肌病的保守性治疗方法也取得了一定的进展,现综述如下.

Reference

[1]何淑明,韦明秀,韩燕华,等.左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察[J].2005,(8).
[2]沈玉莲,金季玲.活血化淤法分期治疗子宫腺肌病27例临床观察[J].2006,(10).
[3]陈春林,刘萍,吕军,等.子宫动脉栓塞术在子宫腺肌病治疗中的应用[J].2002,(2).
[4]盛洁,卢丹,张建萍,等.左炔诺孕酮宫内释放系统治疗子宫腺肌病痛经的临床观察[J].2006,(7).
[5]严红,黄小惠,邓桂芳.针灸治疗子宫肌腺病疗效观察[J].2008,(8).
[6]周应芳,白文佩.子宫腺肌病诊断及治疗研究进展[J].2006,(2).
[7]Lin Jinfang,SUN Cuixiang,ZHENG Huaimei.Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility[J].2000,(5).
[8]李高文,刘素云,朱雪连,等.介入治疗子宫腺肌病的临床分析[J].2002,(8).
[9]刘丽春.消癥散结汤治疗子宫腺肌病96例[J].2007,(2).
[10]刘德艳,顾美皎,舒家振,等.促性腺激素释放激素激动剂延长用药间隔治疗子宫内膜异位症和子宫腺肌病的疗效观察[J].2006,(10).
[11]廖英,李军兰,陈云飞.桂枝茯苓胶囊对子宫腺肌病小鼠病灶组织MMP-2、MMP-7的影响[J].2007,(5).
[12]郭英,廖英.桂枝茯苓丸加味治疗子宫腺肌病的近期临床观察[J].2010,(4).
[13]高燕,杨智敏.子宫动脉栓塞术治疗子宫腺肌病的进展[J].2005,(4).
[14]陈春林,刘萍,曾北蓝,等.子宫动脉栓塞术治疗子宫腺肌病的中远期临床疗效观察[J].2006,(10).
[15]张琴芳,张英,王会凤,等.左炔诺孕酮宫内缓释系统对女性生殖激素水平的影响[J].2006,(11).
[16]邓姗,郎景和,冷金花,等.左炔诺孕酮宫内缓释系统用于防治子宫内膜异位症和子宫腺肌病的临床观察[J].2006,(10).
[17]康佳丽,王小霞,聂妙玲,等.促性腺激素释放激素激动剂延长给药间隔治疗子宫腺肌病和子宫内膜异位症的疗行[J].2008,(5).
[18]张莉嘉,翁梨驹.左炔诺孕酮宫内系统临床使用五年的安全性研究[J].2001,(11).
[19]Ascher SusanM,Cuomo Felicia,Sugimura Kazuro,etc.MR imaging of diffuse adenomyosis changes after GnRH analog therapy.[J].2002,15(3).
[20]Cheng Z,Dai H,Liping H,etc.Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.[J].2009,16(2).
[21].Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis[J].2010,202(4).
[22]Kuwabara Y,Mine K,Takeshita T,etc.Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis.[J].2009,15(1).
[23]Kang S,Zhao J,Liu Q.Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis.[J].2009,50(5).
[24]Cockerham,A.Z..Adenomyosis: A Challenge in Clinical Gynecology[J].2012,57(3).
[25]Kinoshita K,Kitade M,Kikuchi I,etc.Laparoscopic adenomyomectomy and hysteroplasty: a novel method.[J].2006,13(2).
[26]H.H. Cho,M.R. Kim,J.H. Kim,etc.Immunohistochemical changes of adenomyosis after heat therapy: comparison of radiofrequency myolysis and endoablation[J].2012,39(1).
[27]A B, Edelman,M F, Gallo,J T, Jensen,etc.Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception.[J].2005,(3).
[28]Zhang WY,Zhang JP,Sheng J,etc.The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.[J].2009,79(3).
[29]Liu,X.,Nie,J.,Guo,S.-W..Elevated immunoreactivity against class i histone deacetylases in adenomyosis[J].2012,74(1).
[30]Gao,L.,Huang,M.,Feng,X.,etc.Local excision of uterine adenomyomas: A report of 86 cases with follow-up analyses[J].2012,161(1).
[31]丰有吉, 沈铿.妇产科学[M].2010.
[32]罗颂平.中医妇科学[M].2008.
[33]Liang,E.,Brown,B.,Stuart,A.,etc.Efficacy of uterine artery embolisation for treatment of symptomatic fibroids and adenomyosis - An interim report on an Australian experience[J].2012,52(2).
[34]V McCausland,A McCausland.The response of adenomyosis to endometrial ablation/resection[J].1998,4(4).
[35]宋楠,王艳艳,冷金花.散结镇痛胶囊对子宫内膜异位症及子宫腺肌病痛经治疗效果观察[J].2010,(3).
[36]Sylvia Mechsner,Britta Grum,Christine Gericke,etc.Possible roles of oxytocin receptor and vasopressin-1α receptor in the pathomechanism of dysperistalsis and dysmenorrhea in patients with adenomyosis uteri[J].2010,94(7).
[37]Deguara,C.,Pepas,L.,Davis,C..Update on the surgical management of adenomyosis[J].2012,24(4).
[38]James P Senter,D Alan Johns,Michael P Diamond,etc.Hysterectomy subsequent to endometrial ablation.[J].2012,19(4).
[39]Mosbah,A.A.,Badawy,A.M.,Elnashar,A.M..Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: A randomized controlled trial[J].2012,91(4).
[40]Habiba MA,Pringle JH,Mehasseb MK,etc.Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium.[J].2010,93(7).